Again, the sample size was limited, but they observed a decreasing trend in biomarker levels corresponding with effective therapy, whereas persistent rejection was indicated by biomarker levels exceeding threshold test characteristics.
← all excerpts
Can Blood Gene Expression Profile and Donor-Derived Cellfree DNA Guide Postrejection Management among Kidney Transplant Recipients?
1
—
—